David E. Barañano

2.9k total citations · 1 hit paper
19 papers, 2.4k citations indexed

About

David E. Barañano is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, David E. Barañano has authored 19 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in David E. Barañano's work include Retinal Diseases and Treatments (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Iron Metabolism and Disorders (4 papers). David E. Barañano is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Iron Metabolism and Disorders (4 papers). David E. Barañano collaborates with scholars based in United States and Poland. David E. Barañano's co-authors include Solomon H. Snyder, Christopher D. Ferris, Mahil Rao, Roxanne K. Barrow, Herman Wolosker, Sylvain Doré, Samie R. Jaffrey, Akira Sawa, Stephen D. Brady and Masaaki Takahashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

David E. Barañano

19 papers receiving 2.3k citations

Hit Papers

Biliverdin reductase: A major physiologic cytoprotectant 2002 2026 2010 2018 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Barañano United States 13 1.6k 648 395 335 287 19 2.4k
Travis W. Hein United States 32 992 0.6× 76 0.1× 556 1.4× 265 0.8× 249 0.9× 87 3.6k
Josep A. Villena Spain 27 1.7k 1.1× 172 0.3× 114 0.3× 194 0.6× 91 0.3× 42 3.3k
Raymond F. Regan United States 39 1.9k 1.2× 307 0.5× 23 0.1× 387 1.2× 346 1.2× 80 3.4k
Emmanuel S. Buys United States 32 857 0.5× 52 0.1× 243 0.6× 122 0.4× 304 1.1× 99 2.7k
Khalid S. Hasan United States 5 389 0.2× 77 0.1× 180 0.5× 239 0.7× 149 0.5× 10 1.7k
Daniel Abran Canada 25 388 0.2× 377 0.6× 302 0.8× 37 0.1× 29 0.1× 38 1.4k
Qi Zhao China 22 658 0.4× 117 0.2× 73 0.2× 61 0.2× 135 0.5× 82 2.0k
Xiaochuan Sun China 34 1.7k 1.0× 122 0.2× 35 0.1× 148 0.4× 118 0.4× 185 3.9k
Charles W. Heilig United States 23 816 0.5× 174 0.3× 41 0.1× 176 0.5× 120 0.4× 39 1.9k

Countries citing papers authored by David E. Barañano

Since Specialization
Citations

This map shows the geographic impact of David E. Barañano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Barañano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Barañano more than expected).

Fields of papers citing papers by David E. Barañano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Barañano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Barañano. The network helps show where David E. Barañano may publish in the future.

Co-authorship network of co-authors of David E. Barañano

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Barañano. A scholar is included among the top collaborators of David E. Barañano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Barañano. David E. Barañano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sophie, Raafay, Gulnar Hafiz, Adrienne W. Scott, et al.. (2013). Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion. American Journal of Ophthalmology. 156(4). 693–705.e11. 82 indexed citations
2.
Rodrigues, Murilo Wendeborn, Xiaoban Xin, Kathleen Jee, et al.. (2013). VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy. Diabetes. 62(11). 3863–3873. 117 indexed citations
3.
Wenick, Adam S. & David E. Barañano. (2012). Evaluation and management of pediatric rhegmatogenous retinal detachment. Saudi Journal of Ophthalmology. 26(3). 255–263. 42 indexed citations
4.
Ray, Robin, David E. Barañano, & G. Baker Hubbard. (2012). Treatment of Coats’ disease with intravitreal bevacizumab. British Journal of Ophthalmology. 97(3). 272–277. 43 indexed citations
5.
Ray, Robin, David E. Barañano, Jorge A. Fortun, et al.. (2011). Intraoperative Microscope-Mounted Spectral Domain Optical Coherence Tomography for Evaluation of Retinal Anatomy during Macular Surgery. Ophthalmology. 118(11). 2212–2217. 122 indexed citations
6.
Barañano, David E., Jorge A. Fortun, Robin Ray, et al.. (2010). Intraoperative Spectral-Domain Optical Coherence Tomography for Macular Pucker Surgery. Investigative Ophthalmology & Visual Science. 51(13). 269–269. 3 indexed citations
7.
Barañano, David E., et al.. (2010). EPSTEIN-BARR INFECTION OF THE RETINA: CASE REPORT AND REVIEW OF THE LITERATURE. Retinal Cases & Brief Reports. 5(1). 1–5. 17 indexed citations
8.
Barañano, David E., et al.. (2009). Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation. British Journal of Ophthalmology. 93(10). 1387–1390. 41 indexed citations
9.
Barañano, David E., et al.. (2008). Efficacy and Pharmacokinetics of Intraocular Ketorolac and Diclofenac. 49(13). 5606–5606. 1 indexed citations
10.
Barañano, David E.. (2004). Long term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome. British Journal of Ophthalmology. 88(4). 588–589. 24 indexed citations
11.
Barañano, David E., Mahil Rao, Christopher D. Ferris, & Solomon H. Snyder. (2002). Biliverdin reductase: A major physiologic cytoprotectant. Proceedings of the National Academy of Sciences. 99(25). 16093–16098. 889 indexed citations breakdown →
12.
Barañano, David E., Christopher D. Ferris, & Solomon H. Snyder. (2001). Atypical neural messengers. Trends in Neurosciences. 24(2). 99–106. 218 indexed citations
13.
Barañano, David E. & Solomon H. Snyder. (2001). Neural roles for heme oxygenase: Contrasts to nitric oxide synthase. Proceedings of the National Academy of Sciences. 98(20). 10996–11002. 249 indexed citations
14.
Ferris, Christopher D., Michael M. Halassa, David J. Haile, & David E. Barañano. (2001). A mammalian iron transporting ATPase: Functional characterization. Gastroenterology. 120(5). A499–A499. 1 indexed citations
15.
Barañano, David E., Sylvain Doré, Christopher D. Ferris, & Solomon H. Snyder. (2001). Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to neuroprotection in stroke and Alzheimer's disease. Clinical Neuroscience Research. 1(1-2). 46–52. 7 indexed citations
16.
Barañano, David E., Herman Wolosker, Byoung-Il Bae, et al.. (2000). A Mammalian Iron ATPase Induced by Iron. Journal of Biological Chemistry. 275(20). 15166–15173. 111 indexed citations
17.
Barañano, David E. & Christopher D. Ferris. (2000). A mammalian iron transporting atpase: induction by iron. Gastroenterology. 118(4). A896–A896. 1 indexed citations
18.
Ferris, Christopher D., Samie R. Jaffrey, Akira Sawa, et al.. (1999). Haem oxygenase-1 prevents cell death by regulating cellular iron. Nature Cell Biology. 1(3). 152–157. 445 indexed citations
19.
Barañano, David E., et al.. (1999). Identification and characterization of an iron transporting ATPase. 2. 1188–1189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026